Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone and levobupivacaine for chronic pelvic pain after endometriosis surgery
ACTRN12615000765527Phase 4Not yet recruiting
- Sponsor
- Professor Roger Hart
- Start
- Aug 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methadone and levobupivacaine in endometriosis and chronic prostatitis (CP) (2 arms), sponsored by Professor Roger Hart. Primary endpoints: VAS pain scores and Quality of life scores. Planned start Aug 2015; status: not yet recruiting.
02
Drugs
methadonelevobupivacaine
03
Conditions
endometriosischronic prostatitis (CP)
Beyond the preview
Go deeper on ACTRN12615000765527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000765527.